Custom Antibody Market Size
| Study Period | 2019 - 2030 |
| Market Size (2025) | USD 0.63 Billion |
| Market Size (2030) | USD 1.00 Billion |
| CAGR (2025 - 2030) | 9.60% |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Custom Antibody Market Analysis
The Custom Antibody Market size is estimated at USD 0.63 billion in 2025, and is expected to reach USD 1.00 billion by 2030, at a CAGR of 9.6% during the forecast period (2025-2030).
Factors such as the growing importance of custom antibodies in precision medicine, rising research activities and funding investments for antibody development, and advancements in biotechnology and genetic engineering are expected to boost the market growth over the forecast period.
The rising prevalence of chronic and infectious diseases has heightened the demand for specific antibodies in precision medicine. In response, companies are innovating and producing a wider array of custom antibodies. For instance, data from the Australian Institute of Health and Welfare, released in August 2024, reveals that lung cancer, projected to have around 15,000 cases, will become Australia's fifth most commonly diagnosed cancer in 2024. This high burden of cancer among the population highlights the need for innovative treatment, including custom antibody, in a prevalent and impactful disease area. hence, it is expected to bolster the market growth over the forecast period.
Moreover, the age-standardized incidence rate for lung cancer is recorded at 56 cases per 100,000 in 2024. This surge in lung cancer cases intensifies the demand for custom antibodies, which are crucial for identifying specific tumor markers and antigens in blood or tissue samples, thus refining cancer diagnosis and monitoring. Consequently, this heightened focus on diagnosis and treatment is poised to drive market growth in the coming years.
Additionally, as the global population ages, the prevalence and impact of neurological disorders are anticipated to increase, due to the natural aging process, driving up the demand for custom antibodies and subsequently fueling market growth. For instance, research from University College London published in October 2023 underscored a troubling trend as dementia cases in England and Wales are projected to reach 1.7 million by 2040, surpassing earlier estimates. This increase in dementia cases boosts the demand for custom antibodies, which are crucial in both research and clinical fields for identifying dementia-related biomarkers. These antibodies are instrumental in imaging techniques and assays, enabling timely and precise diagnoses, and thus enhancing market growth over the forecast period.
Furthermore, strategic moves like collaborations and partnerships undertaken by the key players are set to accelerate the development of custom antibodies, further driving market growth in the coming years. For instance, in May 2023, PhosphoSolutions unveiled a fresh line of cancer antibodies. This product launch not only underscores the company's dedication to researchers but also emphasizes their provision of premium custom antibodies. Such advancements are poised to amplify the demand for custom antibodies in cancer treatment, further propelling market growth over the forecast period.
Given the widespread prevalence of cancer and neurological disorders, coupled with increased research activities, the launch of new products, and the adoption of collaborative strategies by the players, the studied market is expected to grow over the forecast period. However, the steep costs associated with antibody production could pose challenges, potentially restraining market expansion in the coming years.
Custom Antibody Market Trends
Infectious Diseases Segment is Expected to Witness Fastest Growth Over the Forecast Period
The infectious disease segment is expected to witness significant growth in the custom antibody market owing to the growing burden of hepatitis, tuberculosis, HIV/AIDS, and influenza infection, rising demand for effective diagnostics and treatment methods, high research and development activities by the key players coupled with new product and services launches.
With rising instances of infectious diseases such as tuberculosis (TB), hepatitis, and fungal infections, the segment is witnessing robust growth. For instance, according to the Global Tuberculosis 2024 report, the TB incidence rate (new cases per 100,000 population) in 2023 was 134. Five countries accounted for 56% of the worldwide total: India (26%), Indonesia (10%), China (6.8%), the Philippines (6.8%) and Pakistan (6.3%).
Also, in 2023, 55% of people who developed TB were men, 33% were women and 12% were children and young adolescents. This pronounced TB prevalence accentuates the pressing need for accurate diagnosis and treatment. Such urgency amplifies the demand for custom antibodies, crucial for identifying specific antigens of Mycobacterium tuberculosis. These antibodies not only bolster the precision of TB diagnostic assays but also pave the way for groundbreaking therapeutic strategies, underscoring their expanding role in TB research and clinical applications.
The rising company initiatives to design a protocol to develop custom antibodies for managing and treating various infectious diseases are anticipated to propel the segment growth over the forecast period. For instance, as per the data published by Abyntek Biopharma in July 2023, the company designed a protocol that guarantees the production of custom polyclonal antibodies with a minimum tier of 30,000 at a reduced cost. Such development is expected to boost the adoption of custom antibodies for infectious diseases, further bolstering segment growth.
Thus, owing to the high burden of tuberculosis and rising company initiatives for the development of custom antibodies at reduced cost, the studied segment is expected to grow over the forecast period.
North America is Expected to Dominate the Custom Antibody Market
North America is set to witness a significant market share, fueled by the rising prevalence of various diseases, increasing healthcare expenditures, and heightened research and funding endeavors centered on antibody development. Additionally, biotechnology and genetic engineering breakthroughs are poised to accelerate market growth in the coming years further.
Additionally, collaborative strategies among key players to discover novel antibodies are anticipated to fuel market growth. For instance, in December 2023, Antibody Solutions, a custom antibody service provider, signed a licensing agreement with mAbsolve for its Fc silencing technology. This deal grants Antibody Solutions' clients seamless, license-free access to the innovative STR Fc silencing platform for their antibody research and development endeavors.
Similarly, in March 2024, Sino Biological, Inc. signed a services partnership with Rapid Novor, Inc., a Canada-based company. As per the agreement, Sino Biological will promote Rapid Novor's proprietary de novo REmAb monoclonal antibody (mAb) sequencing service, alongside its own custom mAb development and production services.
Furthermore, a rise in the establishment of new companies dedicated to pioneering monoclonal antibody therapies is set to boost the demand for antibody discovery and development services, propelling market growth. For instance, in October 2023, Sino Biological, Inc. opened its Center for Bioprocessing (C4B) in Texas, United States. This center offers contract research services, emphasizing the development and manufacture of custom recombinant proteins and antibodies. C4B aims to develop and produce research- and diagnostic-grade proteins and antibodies using mammalian cells. These cells have the unique capability to produce natural, in vivo-like products, ensuring high bioactivity.
With increasing government initiatives, funding activities, and strategic maneuvers by key players to propel specific antibody development, the market is poised for expansion during the forecast period.
Custom Antibody Industry Overview
The market for custom antibodies is consolidated owing to the presence of major players dominating the market. The key players are adopting key strategic activities such as collaborations, partnerships, and launches to retain their share in the studied market. The companies are focusing on developing advanced platforms as well as integrating technologies for antibody discovery and production which is expected to increase the adoption of antibody discovery, development, and production services from those companies. Some of the key players in the market are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Abcam plc, Bio-Rad Laboratories, Inc., GenScript, Danaher Corporation and Merck KGaA among others.
Custom Antibody Market Leaders
-
Bio-Rad Laboratories, Inc.
-
Danaher Corporation
-
Thermo Fisher Scientific Inc.
-
Agilent Technologies, Inc.
-
Merck KGaA
- *Disclaimer: Major Players sorted in no particular order
Custom Antibody Market News
- October 2024: Archon Biosciences launched an initiative to utilize artificial intelligence (AI) in designing custom antibody cages with a funding of USD 20 million. This innovative technology aims to enhance an antibody's affinity for its therapeutic target, while simultaneously reducing its interaction with other biomolecules, potentially boosting potency and minimizing toxicity and side effects.
- July 2023: Twist Bioscience Corporation expanded its high-throughput antibody portfolio by introducing a Chinese hamster ovary (CHO) cell line for its Twist Express Antibodies. Alongside the new CHO cell line, Twist continues to utilize HEK293 expression for its Twist Express Antibodies. This strategic initiative is designed to strengthen Twist's position in the biopharma market, enabling them to offer both HEK293 antibodies—benefiting from quicker turnaround times due to their Express Genes, and the newly launched CHO cell line.
Custom Antibody Industry Segmentation
As per the scope of the report, custom antibodies are specifically engineered and produced for targeted research, diagnostic, or therapeutic applications. Tailored to bind to unique target antigens or epitopes, these antibodies offer heightened specificity and efficacy for their intended uses.
The custom antibody market is segmented by type, services, application, end user, and geography. By type, the market is segmented by monoclonal antibodies polyclonal antibodies, recombinant antibodies, and others. The other types include neutralizing antibodies and diagnostic antibodies, among others. By services, the market is segmented by antibody development, antibody production & purification, and antibody fragmentation and labeling. By application, the market is segmented by oncology, infectious diseases, neurology, stem cells, immunology, cardiovascular diseases, and others. The other applications include rare and genetic disorders and autoimmune diseases, among others. By geography, the market is divided into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The market provides the value (in USD) for the above-mentioned segments.
| By Type | Monoclonal Antibodies | ||
| Polyclonal Antibodies | |||
| Recombinant Antibodies | |||
| Others (Neutralizing Antibodies and Diagnostic Antibodies, among others) | |||
| By Service | Antibody Development | ||
| Antibody Production & Purification | |||
| Antibody Fragmentation & Labelling | |||
| By Application | Oncology | ||
| Infectious Diseases | |||
| Neurology | |||
| Stem cells | |||
| Immunology | |||
| Cardiovascular Diseases | |||
| Others (Rare and Genetic Disorders, Musculoskeletol, among others) | |||
| By End User | Pharmaceutical & Biotechnology Companies | ||
| Academic & Research Institutes | |||
| Contract Research Organization | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
| Monoclonal Antibodies |
| Polyclonal Antibodies |
| Recombinant Antibodies |
| Others (Neutralizing Antibodies and Diagnostic Antibodies, among others) |
| Antibody Development |
| Antibody Production & Purification |
| Antibody Fragmentation & Labelling |
| Oncology |
| Infectious Diseases |
| Neurology |
| Stem cells |
| Immunology |
| Cardiovascular Diseases |
| Others (Rare and Genetic Disorders, Musculoskeletol, among others) |
| Pharmaceutical & Biotechnology Companies |
| Academic & Research Institutes |
| Contract Research Organization |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
Custom Antibody Market Research FAQs
How big is the Custom Antibody Market?
The Custom Antibody Market size is expected to reach USD 0.63 billion in 2025 and grow at a CAGR of 9.60% to reach USD 1.00 billion by 2030.
What is the current Custom Antibody Market size?
In 2025, the Custom Antibody Market size is expected to reach USD 0.63 billion.
Who are the key players in Custom Antibody Market?
Bio-Rad Laboratories, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Agilent Technologies, Inc. and Merck KGaA are the major companies operating in the Custom Antibody Market.
Which is the fastest growing region in Custom Antibody Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Custom Antibody Market?
In 2025, the North America accounts for the largest market share in Custom Antibody Market.
What years does this Custom Antibody Market cover, and what was the market size in 2024?
In 2024, the Custom Antibody Market size was estimated at USD 0.57 billion. The report covers the Custom Antibody Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Custom Antibody Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Custom Antibody Industry Report
Statistics for the 2025 Custom Antibody market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Custom Antibody analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
